BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30034253)

  • 1. The miR-200 family: multiple effects on gliomas.
    Peng L; Fu J; Ming Y
    Cancer Manag Res; 2018; 10():1987-1992. PubMed ID: 30034253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miR-200b/200a/429 cluster prevents metastasis and induces dormancy in a murine claudin-low mammary tumor cell line.
    Watson KL; Jones RA; Bruce A; Moorehead RA
    Exp Cell Res; 2018 Aug; 369(1):17-26. PubMed ID: 29702103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of miR-200b and cancer chemosensitivity.
    Feng B; Wang R; Chen LB
    Biomed Pharmacother; 2012 Sep; 66(6):397-402. PubMed ID: 22795796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory roles of the miR-200 family in neurodegenerative diseases.
    Fu J; Peng L; Tao T; Chen Y; Li Z; Li J
    Biomed Pharmacother; 2019 Nov; 119():109409. PubMed ID: 31518873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.
    Ma CC; Xiong Z; Zhu GN; Wang C; Zong G; Wang HL; Bian EB; Zhao B
    J Exp Clin Cancer Res; 2016 Jun; 35(1):90. PubMed ID: 27267902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-200c as a Prognostic Biomarker for Pancreatic Cancer.
    Paik WH; Song BJ; Kim HW; Kim HR; Hwang JH
    Korean J Gastroenterol; 2015 Oct; 66(4):215-20. PubMed ID: 26493507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis.
    Wong CM; Wei L; Au SL; Fan DN; Zhou Y; Tsang FH; Law CT; Lee JM; He X; Shi J; Wong CC; Ng IO
    Oncotarget; 2015 May; 6(15):13658-70. PubMed ID: 25909223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models.
    Higaki S; Muramatsu M; Matsuda A; Matsumoto K; Satoh JI; Michikawa M; Niida S
    PLoS One; 2018; 13(5):e0196929. PubMed ID: 29738527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of miR‑200 family in brain metastases: A systematic review.
    Fotakopoulos G; Georgakopoulou VE; Spandidos DA; Papalexis P; Angelopoulou E; Aravantinou-Fatorou A; Trakas N; Trakas I; Brotis AG
    Mol Clin Oncol; 2023 Mar; 18(3):15. PubMed ID: 36798467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene regulation and prognostic indicators of lung squamous cell carcinoma: TCGA-derived miRNA/mRNA sequencing and DNA methylation data.
    Shen Y; Pan X; Yang J
    J Cell Physiol; 2019 Dec; 234(12):22896-22910. PubMed ID: 31169310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
    Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
    Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of the miR-126 gene associated with glioma progression.
    Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
    Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200b and microRNA-200c are up-regulated in PCOS granulosa cell and inhibit KGN cell proliferation via targeting PTEN.
    He T; Sun Y; Zhang Y; Zhao S; Zheng Y; Hao G; Shi Y
    Reprod Biol Endocrinol; 2019 Aug; 17(1):68. PubMed ID: 31421682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.